Device Trial Radar · NCT04972097
Pivotal Study of the NanoKnife System for the Ablation of Prostate Tissue
Last checked: Nov 20, 2026Latest source record: Jun 2, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
121
Actual
Start
Mar 29, 2022
Primary completion
Aug 14, 2024
Study completion Aug 14, 2024
Sponsor
- Lead sponsor
- Angiodynamics, Inc.Not on our public-company list
- Sponsor type
- Industry
- First posted
- Jul 22, 2021
Design
- Study type
- Interventional
- Phase
- Not applicable (typical for device studies)
- Allocation
- Not applicable (single group)
- Model
- Single group
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated device
- Yes
- Who can join
- Male only, from 50 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
Pivotal study to evaluate the use of the NanoKnife System as a focal therapy option for prostate cancer patients. This study will assess the safety and effectiveness of the device when used to ablate prostate tissue in intermediate-risk prostate cancer patients.
Conditions
- Prostate Cancer
Interventions
Irreversible ElectroporationDevice
IRE of the prostate is typically performed with the subject in the lithotomy position, with 2-6 monopolar probes placed through the perineum using a brachytherapy grid and ultrasound or CT guidance. IRE supplies the targeted tissue with high voltage (2-3 kV) direct current pulses lasting up to 100 microseconds through the electrode probes.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Number of Participants With a Negative In-field Biopsy at 12 MonthsTime frame: 12 months
- Number of Participants With Device-related Adverse Events Through 12 MonthsTime frame: 12 months
Locations
17 sites in 1 country. Site status is shown where the registry gives one.
University of California Irvine
Orange, California
University of Colorado
Aurora, Colorado
University of Florida Health
Gainesville, Florida
14 more study sites with a free account
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.